Rekha Hemrajani
CIK 1771213 · President and CEO · last filed 2026-06-05
Rekha Hemrajani is a President and CEO who has filed 27 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing, for LBRX, was dated Jun 5, 2026. Across all open-market trades the lifetime net is +$135.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $150.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$150.9K
7
27
$135.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LBRX | Director | — | $28.42 | — | $0 | 2 | 2026-06-05 |
| ALXO | Director | 33,000 | $1.58 | $52.1K | $103.4K | 8 | 2026-01-21 |
| MXCT | Director | 39,893 | $1.12 | $44.7K | -$22.4K | 7 | 2025-08-27 |
| BIOA | Director | 3,000 | $18.04 | $54.1K | $54.0K | 3 | 2025-06-09 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | — | $4.36 | — | $0 | 4 | 2020-06-25 |
| Aravive, Inc. (ARAV) Delisted | President and CEO | 14,250 | $0.04 | $571 | $0 | 2 | 2020-04-09 |
| RCUS | See Remarks | — | $23.80 | — | $0 | 1 | 2019-03-25 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | LBRX | Grant (A) | — | $0 | EDGAR |
| 2026-01-21 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-09-12 | LBRX | Grant (A) | — | $0 | EDGAR |
| 2025-08-27 | MXCT | Sell (S) | −10,684 | -$22.4K | EDGAR |
| 2025-06-23 | MXCT | Grant (A) | +29,210 | $0 | EDGAR |
| 2025-06-09 | BIOA | Grant (A) | — | $0 | EDGAR |
| 2025-03-10 | BIOA | Buy (P) | +3,000 | $54.0K | EDGAR |
| 2025-01-23 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-12-04 | ALXO | Buy (P) | +30,000 | $46.4K | EDGAR |
| 2024-09-27 | BIOA | Grant (A) | — | $0 | EDGAR |